Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Indikator
Negara-negara
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Kalender
Berita
Pasar
Komoditas
Indeks
Saham
Mata Uang
Kripto
Obligasi
Pendapatan
Liburan
Negara-negara
Amerika Serikat
Inggris Raya
Kawasan Euro
Australia
Kanada
Jepang
Tiongkok
Brazil
Rusia
India
Selanjutnya Negara-negara
Indikator
Tingkat Bunga
Tingkat Inflasi
Tingkat Pengangguran
Pertumbuhan PDB (q-to-q)
Pdb Per Kapita
Transaksi Berjalan
Cadangan Emas
Utang Pemerintah
Produksi Minyak Mentah
Harga Bensin
Peringkat Kredit
Selanjutnya Indikator
Prakiraan
Komoditas
Indeks
Mata Uang
Kripto
Obligasi
Negara-negara
Indikator
Apps
App Store
Google Play
Twitter
Light
Dark
System
Revvity | PKI - Biaya Operasional
Keuangan
Harga Saham
USD 145.22
Aktiva
USD 11.49B
Kas Dan Setara
USD 592.8M
Biaya Penjualan
USD 310.32M
Aset Lancar
USD 1.86B
Kewajiban Lancar
USD 701.48M
UTANG
USD 2.63B
Dividen - Hasil
0.19
EBIT
USD 124.63M
EBITDA
USD 227.55M
Karyawan
11K
Eps Laba Per Saham
USD 1.37
Modal Dan Cadangan
USD 7.23B
Laba Kotor Pada Penjualan
USD 418.58M
Beban Bunga Utang
USD 20.81M
Pendapatan Bunga
USD -22.99M
Modal Pinjaman
USD 2.63B
Kapitalisasi Pasar
USD 18.5B
Batas Pemasukan
USD 62.3M
Biaya Operasional
USD 604.27M
Laba Operasional
USD 124.63M
Modal Saham Biasa
USD 111.59M
Pe Harga Untuk Laba
56.86
Laba Sebelum Pajak
USD 187.24M
Pendapatan Penjualan
USD 729M
Beban Penjualan Dan Administrasi
USD 275.33M
Saham
USD 388.85M
Kreditur Perdagangan
USD 163.27M
Debitur Perdagangan
USD 687.33M
Biaya Operasional
Perubahan
Tanggal
Agilent
USD 1.43B
2M
2026-06
Align Technology
USD 821.72M
43.15M
2026-09
Bio Techne
USD 243.9M
17.7M
2026-09
Bio-Rad Laboratories
USD 7.6B
429.1M
2026-09
Bruker
USD 790.5M
21.6M
2026-09
Celltrion
KRW 133.99B
14.77B
2026-06
Charles River Laboratories
USD 3.23B
387.38M
2026-09
Cspc Pharmaceutical
CNY 5.91B
512.77M
2025-12
Danaher
USD 53.62B
1.04B
2026-09
Dentsply International
USD 1.36B
4M
2026-09
Deva Holding AS
TRY 1.35B
178.26M
2023-09
Dianthus Therapeutics
USD 62.24M
15.25M
2026-06
Divis Laboratories Ltd
INR 22.52B
3.01B
2026-09
Edwards Lifesciences
USD 10.86B
9.64B
2026-09
Illumina
USD 525M
374M
2026-09
Intuitive Surgical
USD 2B
86.5M
2026-09
IQVIA Holdings
USD 3.82B
2.05B
2026-09
Kangmei Pharma
CNY 1.22B
130.32M
2026-06
Knight Therapeutics
CAD 126.9M
8.29M
2025-12
Laboratorios Farma
EUR 313.62M
17.98M
2023-12
Laboratory Of America
USD 3.39B
117.6M
2026-09
Malin Corporation
EUR 1.1M
400K
2024-12
Medical Developments International
AUD 21.61M
11.59M
2025-12
Mesa Laboratories
USD 33.98M
2.03M
2024-12
Mettler Toledo International
USD 77.66M
662.11M
2026-09
Myriad Genetics
USD 212.8M
16.2M
2025-12
Neuren Pharmaceuticals
AUD 25.23M
16.54M
2025-12
OraSure Technologies
USD 40.35M
2.45M
2025-12
Organigram Holdings
CAD 100.45M
30.86M
2026-06
Ovoca Bio
EUR 173K
990K
2025-12
Pacific Biosciences Of California
USD 97.83M
41.29M
2025-12
Pharma Mar
EUR 46.77M
4.24M
2026-09
Qiagen NV
USD 393.64M
17.95M
2026-06
Quest Diagnostics
USD 2.62B
34M
2026-09
Quidel
USD 606.8M
39.4M
2026-09
Repligen
USD 185.01M
2.01M
2026-09
Revvity
USD 604.27M
719K
2026-09
Sartorius
EUR 746.5M
1.3M
2026-09
Sino Biopharmaceutical
CNY 12.39B
1.26B
2025-06
Thermo Fisher Scientific
USD 9.68B
134M
2026-09
Tilray
USD 237.52M
17.34M
2025-09
Waters
USD 527M
592M
2026-06
Zealand Pharma A/S
573M
202.97M
2026-03
Zz Pientze Pharmaceu
CNY 1.54B
90.74M
2026-09
×